Red Heart Pill

The Red Heart Pill is a fixed-dose combination medication developed as a "polypill" for the prevention of cardiovascular events in individuals at high risk or with established cardiovascular disease. It contains four active pharmaceutical ingredients: low-dose aspirin (an antiplatelet agent), a statin (cholesterol-lowering agent), and two blood pressure-lowering medicines. The specific statin and antihypertensive agents may vary by formulation but are typically generic drugs such as simvastatin or atorvastatin for cholesterol management, and commonly used antihypertensives like an ACE inhibitor/ARB and a thiazide diuretic or beta-blocker. The pill is designed to simplify therapy, improve adherence, reduce costs, and lower the risk of recurrent heart attack or stroke by up to 55%. It has been studied in large international clinical trials for both secondary prevention (patients with prior events) and primary prevention (patients at moderate-to-high risk). The product was developed primarily to address access barriers in low- and middle-income countries but has also been trialed in high-income settings[4][5].

Brand names

Red Heart Pill

Other names

RHPheart polypillcardiovascular polypill